Novacyt secures €4.0m funding through unsecured debt facility to support M&A strategy

Novacyt Funding Paris, France and Camberley, UK – 30 May 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that on 29 May 2018, it entered into a new €4.0 million unsecured debt facility from a French institutional investor (the “Facility”).

Visit Page

Publication of Annual Report and Notice of AGM

Posting of AR and Notice of AGM FINAL Paris, France and Camberley, UK – 23 May 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces that the Company’s Annual Report and Accounts (“Annual Report”) for the year ended 31 December 2017 has today been published and uploaded to

Visit Page